Moxifloxacin Hydrochloride Eye Drops
Belongs to Category:
The company has production licenses for tablets, capsules, granules, suppositories, powders, injections, oral solutions, dry suspensions, and eye drops.
Product Description
Approval Number:
H20234193
Indications:
For the treatment of bacterial conjunctivitis caused by the following sensitive microorganisms:
Gram-positive bacteria:
Corynebacterium spp.*
Micrococcus luteus*
Staphylococcus aureus
Staphylococcus epidermidis
Staphylococcus haemolyticus
Staphylococcus hominis
Staphylococcus warneri*
Streptococcus pneumoniae
Viridans streptococci group
Gram-negative bacteria:
Acinetobacter lwoffii*
Haemophilus influenzae
Haemophilus parainfluenzae*
Acinetobacter baumannii
Acinetobacter junii*
Stenotrophomonas maltophilia*
Chryseobacterium spp.*
Other microorganisms:
Chlamydia trachomatis
*Studies on the efficacy against these microorganisms included fewer than 10 cases.
Administration:
Instill 1 drop into the affected eye 3 times daily for 7 consecutive days.
Specifications:
0.5% (3ml:15mg)
0.5% (5ml:25mg)
The company has production licenses for tablets, capsules, granules, suppositories, powders, injections, oral solutions, dry suspensions, and eye drops.
The main products cover cardiovascular diseases, diabetic complications, anti-tumor, calcium supplementation, digestive system, respiratory system, and orthopedics.
Related Products
Online Message
We will contact you within one business day. Please pay attention to your email.
Mobile Version QR Code
Whatsapp Account
Copyright © 2025 Jiangsu Wangao Pharmaceutical Co., Ltd.